1. Home
  2. WEYS vs PRTA Comparison

WEYS vs PRTA Comparison

Compare WEYS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEYS
  • PRTA
  • Stock Information
  • Founded
  • WEYS 1906
  • PRTA 2012
  • Country
  • WEYS United States
  • PRTA Ireland
  • Employees
  • WEYS N/A
  • PRTA N/A
  • Industry
  • WEYS Apparel
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEYS Consumer Staples
  • PRTA Health Care
  • Exchange
  • WEYS Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • WEYS 303.5M
  • PRTA 351.5M
  • IPO Year
  • WEYS N/A
  • PRTA N/A
  • Fundamental
  • Price
  • WEYS $28.50
  • PRTA $6.81
  • Analyst Decision
  • WEYS
  • PRTA Buy
  • Analyst Count
  • WEYS 0
  • PRTA 9
  • Target Price
  • WEYS N/A
  • PRTA $27.67
  • AVG Volume (30 Days)
  • WEYS 9.2K
  • PRTA 795.6K
  • Earning Date
  • WEYS 08-05-2025
  • PRTA 08-04-2025
  • Dividend Yield
  • WEYS 3.79%
  • PRTA N/A
  • EPS Growth
  • WEYS N/A
  • PRTA N/A
  • EPS
  • WEYS 3.04
  • PRTA N/A
  • Revenue
  • WEYS $286,762,000.00
  • PRTA $137,935,000.00
  • Revenue This Year
  • WEYS N/A
  • PRTA N/A
  • Revenue Next Year
  • WEYS N/A
  • PRTA $122.46
  • P/E Ratio
  • WEYS $9.57
  • PRTA N/A
  • Revenue Growth
  • WEYS N/A
  • PRTA 54.55
  • 52 Week Low
  • WEYS $25.51
  • PRTA $4.32
  • 52 Week High
  • WEYS $41.05
  • PRTA $23.66
  • Technical
  • Relative Strength Index (RSI)
  • WEYS 29.46
  • PRTA 59.66
  • Support Level
  • WEYS $31.40
  • PRTA $6.74
  • Resistance Level
  • WEYS $32.05
  • PRTA $7.33
  • Average True Range (ATR)
  • WEYS 0.89
  • PRTA 0.32
  • MACD
  • WEYS -0.44
  • PRTA 0.03
  • Stochastic Oscillator
  • WEYS 4.36
  • PRTA 55.56

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: